Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2017

View Archived Issues

Shire reports key events of second quarter 2017

Daiichi Sankyo signs investment contract with Osaka University spin-off Cuorips

Novel LpxC inhibitor demonstrates efficacy in mouse model of bubonic plague

Kiromic conducts four phase I/II trials of its TAPA-pulsed dendritic cell vaccine

Extracellular phosphorylation of EphB2 regulates pathological pain

First-in-human results for prophylactic mRNA-based rabies vaccine

Induced pluripotent stem cells used to generate neurons for study of tau aggregation

Cyclacel selects recommended phase II dose for CYC-065

Zynerba Pharmaceuticals presents topline data from phase II STAR 1 trial of ZYN-002

Alligator Bioscience and Stanford University expand immuno-oncology collaboration

Phase III OPTIMA trial of ThermoDox in primary liver cancer recommended to continue

Positive topline data from first patient cohort of PIONEER-HCM phase II trial of mavacamten

FDA issues complete response letter for latanoprostene bunod NDA

FibroGen reports phase II topline data on pamrevlumab in IPF

FDA awards orphan drug designation to Mytesi for short bowel syndrome

Gemphire presents topline data from ROYAL-1 phase IIb study of gemcabene

Zelboraf granted priority review and breakthrough therapy designation for Erdheim-Chester disease

Piclidenoson completes cardiodynamic safety study

Rebiotix initiates phase III trial of RBX-2660 to prevent recurrent C. difficile infection

Janssen reports results of APPROACH study of Ad26.Mos.HIV HIV-1 vaccine regimens

AntriaBio acquires rights to ActiveSite's plasma kallikrein inhibitor program

FDA grants orphan drug designation to tesevatinib for EGFR-mutated NSCLC

Mylan receives PEPFAR tentative approval for TLD fixed-dose combination regimen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...